SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
107Tuck, As stated...I wish you luck with NKTR, but the trading trend on this puppyArthur Radley-9/8/2006
106Came across this slightly dated bear case from diabeticinvestor.com : www.diabetuck-9/8/2006
105This patent from late last year describes the probable next generation formulatituck-9/8/2006
104I have not been trading either NKTR or MNKD, but I own NKTR and watch MNKD prettRocky9-9/2/2006
103Observation only...but has anyone tracked the trading in NKTR and MNKD as of latArthur Radley-9/1/2006
102Diabetes/obesity also a problem in India, but a somewhat different genetic and ltechnetium-8/25/2006
101Well you know how we Arkies feel about Texans! JonRobohogs-8/22/2006
100Having in mind highly binary nature of the trial result, Oct and Dec options (bohmpa-8/22/2006
99Jon...just confirms that I don't have a clue..(:>) Oops! Texans are suppArthur Radley-8/22/2006
98The EMIS trials are also in India. JonRobohogs-8/22/2006
97I agree...EMIS is the one to watch. I did own the stock but I took a little profArthur Radley-8/22/2006
96Oral insulin may have some bona fide advantages in efficacy. We’ll probably haveDewDiligence_on_SI-8/22/2006
95Looks like a paid ad for the pill company. JonRobohogs-8/22/2006
94biz.yahoo.comArthur Radley-8/22/2006
93MS had been very, very openly critical. Remember, there other big negative stocRobohogs-8/18/2006
92Up about $0.40 to $0.60 today. Couldn't see any news other than Nektar TherIan@SI-8/18/2006
91Soros likes NKTR and other biotechs. Courtesy of TexasDude on the Biotech ValuaIan@SI-8/14/2006
90Here's one guy that really doesn't like NKTR ... 09:25 am Nektar TherapIan@SI-8/4/2006
89>>Nektar Announces Second Quarter 2006 Results Thursday August 3, 4:20 pm tuck-8/4/2006
88OT: EMIS Cary, I parted ways with EMIS at $29. So that would have been late Ian@SI-8/2/2006
87OT: Ian, Thanks for your words of wisdom on EMIS. I took a small position this mArthur Radley-8/2/2006
86EMIS’ Phase-2 results from the oral insulin trial in India are due in September.DewDiligence_on_SI-8/2/2006
85OT EMIS: Oral heparin being tested a few years ago was not a small molecule. Ian@SI-8/2/2006
84Follow EMIS loosely. I seem to recall they had difficulties in the clinic with tuck-8/2/2006
83Tuck...Do you follow EMIS? IMO, if they can develop an oral delivery of insulinArthur Radley-8/2/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):